Aethlon Medical, Inc. (NASDAQ:AEMD) Short Interest Update

Aethlon Medical, Inc. (NASDAQ:AEMD) saw a significant decline in short interest in May. As of May 31st, there was short interest totalling 453,100 shares, a decline of 74.1% from the May 15th total of 1,750,000 shares. Currently, 5.6% of the shares of the company are short sold. Based on an average daily volume of 2,950,000 shares, the short-interest ratio is presently 0.2 days.

Aethlon Medical Stock Performance

Shares of NASDAQ AEMD opened at $0.69 on Friday. The firm has a market capitalization of $1.80 million, a price-to-earnings ratio of -0.14 and a beta of 1.60. The stock has a 50 day moving average price of $0.99 and a 200 day moving average price of $1.54. Aethlon Medical has a 52-week low of $0.37 and a 52-week high of $5.00.

Wall Street Analyst Weigh In

A number of equities research analysts recently commented on the company. StockNews.com assumed coverage on Aethlon Medical in a research report on Friday, June 7th. They issued a “sell” rating on the stock. HC Wainwright reduced their price objective on Aethlon Medical from $23.00 to $10.00 and set a “buy” rating on the stock in a research note on Monday, March 4th.

Aethlon Medical Company Profile

Aethlon Medical, Inc, a medical therapeutic company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It develops Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and use in organ transplantation.